Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline

Caribou Biosciences, a company co-founded by CRISPR pioneer Jennifer Doudna, raised $115 million in a Series C financing, money that will go toward bolstering its research into gene-editing and cell therapy.